A tumor imaging platform supported by AI to improve cancer surgery.
See the platform3Sonic is a device under development. It is not CE marked and is not yet available for sale.
At 3SONIC, we aim to transform the way cancer surgeries are performed. By combining real-time 3D ultrasound imaging with advanced AI, our platform is designed to enable rapid margin assessment of surgical specimens—directly inside the operating room. Faster decisions. Greater precision. Better outcomes.
Designed for real-time, instant use in the operating room.
Completed with oral cancer patients.
Designed to support surgical precision and reduce treatment-related costs.
A fully functional prototype of the imaging platform is built.
Strong demand in the global medical imaging sector.
A compelling opportunity for venture capital funding to fuel further development and market penetration.
A new AI technology from 3SONIC, Rigshospitalet and DTU aims to support critical decision-making during cancer surgeries, an innovation with the potential to save lives.
Read moreThrough the BETA.HEALTH program, we are validating and maturing the 3Sonic platform at Rigshospitalet. The goal is clear: providing surgeons with real-time 3D imaging in the OR to reduce repeat surgeries and improve survival rates.
Read moreNo patient should have to go through a second surgery due to missed cancer tissue. 3Sonic is developing technology intended to let surgeons verify tumor margins with precise 3D ultrasound in under 10 minutes.
Read more
Innovation Fund Denmark
BioInnovation Institute
BETA.HEALTH
Danish Life Science Cluster
&Robin
